Mark Ragosa serves as Executive at Kiniksa Pharmaceuticals, Ltd., where they oversee executive responsibilities. Since joining the company, Mark Ragosa has executed 53 insider transactions totaling $4.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 16, 2022 involved selling 303 shares valued at $3.1K.
Mark Ragosa currently holds 19,086 shares of Kiniksa Pharmaceuticals, Ltd. (KNSA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Ragosa has been a net seller of KNSA stock. They have purchased $0 and sold $4.6M worth of shares.
Mark Ragosa's most recent insider trade was on Mar 16, 2022, when they sold 303 shares at $10.13 per share.
Get notified when new Form 4 filings are submitted
| $17.67 |
| Discretionary |
| Dec 31, 2020 | KNSA | $0 | Option Exercise | 4,404 | $N/A | Discretionary |